Discovery of Novel Blood Biomarkers for PTSD and TBI

Biological Psychiatry 2018; 83(9): S134-135. Supplement
Authored By:
Fossati S, Cejudo JR, Genfi A, Abu-Amara D, Marmar C
The development of blood biomarkers for PTSD and TBI is an extremely critical area of research. Easily detectable blood biomarkers are needed for diagnostic purposes, to establish therapeutic efficacy, to better understand the biology underlying these disorders.
Published in:
Biological Psychiatry

More Publications

May 19, 2023

Nature Reviews Neurology

Global synergistic actions to improve brain health for human development

April 20, 2023

Nature Mental Health

Machine learning-based identification of a psychotherapy-predictive electroencephalographic signature in PTSD

February 13, 2023

Frontiers in Aging Neuroscience

Machine learning within the Parkinson’s progression markers initiative: Review of the current state of affairs

September 9, 2022


Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors

June 1, 2022

JAMA Network Open

Association of Posttraumatic Stress Disorder With Accelerated Cognitive Decline in Middle-aged Women

March 23, 2022

Journal of Neurotrauma

A Framework to Advance Biomarker Development in the Diagnosis, Outcome Prediction, and Treatment of Traumatic Brain Injury